Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer.

in Endocrine-Related Cancer
Authors:
S K Kang Department of Obstetrics and Gynaecology, University of British Columbia, 2H-30, 4490 Oak Street, Vancouver, BC V6H 3V5, Canada.

Search for other papers by S K Kang in
Current site
Google Scholar
PubMed
Close
,
K-C Choi Department of Obstetrics and Gynaecology, University of British Columbia, 2H-30, 4490 Oak Street, Vancouver, BC V6H 3V5, Canada.

Search for other papers by K-C Choi in
Current site
Google Scholar
PubMed
Close
,
H-S Yang Department of Obstetrics and Gynaecology, University of British Columbia, 2H-30, 4490 Oak Street, Vancouver, BC V6H 3V5, Canada.

Search for other papers by H-S Yang in
Current site
Google Scholar
PubMed
Close
, and
P C K Leung Department of Obstetrics and Gynaecology, University of British Columbia, 2H-30, 4490 Oak Street, Vancouver, BC V6H 3V5, Canada.

Search for other papers by P C K Leung in
Current site
Google Scholar
PubMed
Close
Free access

Sign up for journal news

Gonadotrophin-releasing hormone (GnRH) functions as a key neuroendocrine regulator of the hypothalamic-pituitary-gonadal axis. In addition to the hypothalamus and pituitary gland, GnRH and its receptor have been detected in other reproductive tissues including the gonads, placenta and tumours arising from these tissues. Recently, a second form of GnRH (GnRH-II) and type II GnRH receptor have been found in normal ovarian surface epithelium and neoplastic counterparts. The two types of GnRH may play an important role as an autocrine/paracrine regulator of reproductive functions and ovarian tumour growth. In this review, the distribution and potential roles of GnRH-I/-II and their GnRH receptors in the ovarian cells and ovarian cancer will be discussed.

 

  • Collapse
  • Expand